Key People

CCTAM Steering Committee Members

Dr. Choudhri joined Bayer Corporation in 1999 and has had significant experience with the Bayer US medical and Global Development organizations. Before assuming his current role as Head of Medical and Scientific Affairs (M&SA) in Canada, Dr. Choudhri was the Global Clinical Leader, Anti-Infectives with the Bayer Global Clinical Development group. As Head of M&SA for Bayer Inc Dr. Choudhri is responsible for contributing to the Canadian and International development, registration, and post-registration scientific/medical support for Bayer’s pharmaceutical products.

Dr. Choudhri obtained his MD from the University of Manitoba and also did his specialty training in Internal Medicine and sub-specialty training in Infectious Diseases in Manitoba. He then completed a senior research fellowship in Nairobi, Kenya and in 1996 was awarded the Young Investigator Award by the Canadian Association of HIV Researchers. Dr. Choudhri has authored or co-authored over 100 scientific abstracts and has contributed to over 40 publications in peer reviewed journals.

Prior to joining Bayer, he was an Assistant professor in the Departments of Medical Microbiology and Internal Medicine at the University of Manitoba, Director of the HIV/AIDS program at the St. Boniface General Hospital and the Manitoba Satellite Director for the Canadian HIV Clinical Trials Network.

Dr. Robert McMaster is Vice President of Research at Vancouver Coastal Health Authority. His research interests are in the areas of molecular immunology, parasitology and transplant immunology. He currently holds grants from the Canadian Institute for Health Research (CIHR) and is co-lead on a multi-million dollar initiative “Biomarkers in Transplantation” with funding from Genome Canada/Genome BC and the Prevention of Epidemic Organ Failure (PROOF) Centre of Excellence. He is actively involved with national and international granting agencies including the World Health Organization, CIHR and the Michael Smith Foundation for Health Research.

Rob has occupied leadership positions in the Women’s Health Centre for British Columbia and Vancouver Coastal Health Research Institute.

Dr. McMaster received a Bachelor and Master of Science from UBC, which was followed by a D.Phil. from the University of Oxford.

Before joining Innovative Medicines Canada in August 2016, Dr. Chander Sehgal was Director of Common Drug Review (CDR) and Optimal Use of drugs at CADTH (Canadian Agency for Drugs and Technologies in Health) from April 2011 to July 2016. Chander successfully led the CDR program through several procedural upgrades and a period of backlogs. Chander is known as a strategic and collaborative leader who believes in bringing people together to solve complex business problems.

Chander is an Oncologist by background and has worked in the pharmaceutical industry for six years across various functions including Clinical Research, Medical Affairs, Health Economics and Outcomes Research, Reimbursement Planning as well as Market Access. Chander completed a full-time MBA at the Richard Ivey School of Business, University of Western Ontario, London, Ontario in 2009 and specialized in the healthcare stream. Chander has also completed a postgraduate program in Health Economics from the Center of Health Economics, University of York, UK.

Chander’s current role is Executive Director, Access and Reimbursement Policy and Medical Affairs lead at Innovative Medicines Canada.

Address
60 Cambridge St. North
Annex D – Saint Vincent Hospital
Ottawa, ON, K1R 7A5
Copyrights © 2020 CCTAM | All rights reserved.